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ABSTRACT 
The drugs having a narrow absorption window in the gastrointestinal tract (GIT) when administered by oral route are often limited by poor 
bioavailability due to incomplete drug release and short residence time at the site of absorption. Novel drug delivery systems in the form of 
gastroretentive systems such as floating systems, mucoadhesive, high-density, expandable have been developed as they provide controlled 
delivery of drugs with prolonged gastric residence time. Liquid orals are more prone to low bioavailability because they are eliminated quickly 
from the stomach since they are subjected to faster transit from the stomach/ duodenum. The problems of immediate release and short 
gastrointestinal residence of liquids are eliminated by formulating as oral in situ gels as they provide the best means to overcome these 
problems The in situ gel dosage form is a liquid before administration and after it comes in contact with gastric contents due to one or more 
mechanisms gets converted to gel which floats on gastric contents. This achieves increased residence as well as sustained release. This approach 
is useful for systemic as well as local effect of drugs administered. This review gives a brief idea about floating oral in-situ gel formation and 
research done by various scientists on a number of drugs and polymers. 
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INTRODUCTION 
Floating Drug Delivery System is one of the novel system of 
drug delivery. Various dosage forms are formulated in the 
form gastro retentive floating systems such as microspheres, 
micro beads, tablets, capsules, films etc. In-situ gelling 
system is a new trend in floating DDS. In-situ gelling system 
have its application in different routes of administration like 
oral, nasal, ophthalmic, peroral, rectal, vaginal and also 
parenteral route. In situ forming polymeric drug delivery 
systems has many advantages such as ease of administration, 
increased local bioavailability, reduced dose frequency, 
improved patient compliance and has less complex method 
of production and so is cost effective. Gastro retentive FDDS 
have bulk density lower than gastric fluid and hence remain 
buoyant in stomach without affecting the gastric emptying 
rate for a long period of time. When the gel so formed float 
on gastric fluid the drug get released slowly at desired rate 
from the floating gel. After drug is released from floating 
system, the residual part is emptied from stomach. This may 
increase GRT and also control the fluctuations in plasma 
drug concentration (PCD). Floating system are the controlled 
or sustained release dosage form and have properties similar 
to hydrophilic matrices and so called as hydrodynamically 
balanced system (HBS) as they form a low density polymeric 
gel barrier at outer surface. Drug is slowly released from the 
matrices same as that in case of conventional hydrophilic 
matrices. This form may remain buoyant (8-10 hours) on 
gastric contents without affecting the rate of gastric 
emptying. Different polymer systems are used in floating 
drug delivering dosage forms. Among those some are 
polysaccharides, polymethacrylates, hydrocolloids etc. in this 
cellulose ether polymers are most popular, especially HPMC. 
The formulation of floating in situ gelling solution may 
sustain and prolong drug action, improve patient compliance 
and reduce frequency of administration of the drug in 
comparison to conventional drug delivery system1-9. Floating 
drug delivery system (FDDS) was first described by Davis in 
1968. FDDS is an effective technology to prolong the gastric 
residence time in order to improve the bioavailability of the 
drug. Floating drug delivery systems meant for gastric 
retention, float on the surface of the gastric fluids, due to 
their low density and produce prolonged effect by showing 
the controlled release. This type of delivery system is of 
great value for drugs which get absorbed from upper part of 
the stomach i.e. their absorption window resides in upper 
part of stomach. It is also useful for drugs which are inserting 
at alkaline pH of intestine and remains unabsorbed or causes 
side effects due to insolubility. The FDDS are particularly 
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useful for drugs required for their local effect in stomach. 
Though, immediate floating of the delivery system can only 
be achieved if the density of the delivery system is on lower 
side. Delivery system with higher density, initially settle 
down in stomach and then absorb water, swell and then float 
due to decrease in density of the system. But, with such 
system, there may be a possibility of gastric emptying of 
system, before the floating starts. Low density of system, 
which leads to floating, rendered either by incorporation of 
low density excipients or by providing a mechanism which 
leads to air entrapment within the system may have their 
own certain limitations. 
CLASSIFICATION OF FLOATING DRUG DELIVERY 
SYSTEMS 
Based on the mechanism of buoyancy, two distinctly 
different technologies have been utilized in the development 
of Floating Drug Delivery Systems10-14. 
1. Effervescent systems 
These buoyant delivery systems utilize matrices prepared 
with swellable polymers such as Methocel or 
polysaccharides, e.g., chitosan, and effervescent components, 
e.g., sodium bicarbonate and citric or tartaric acid or 
matrices containing chambers of liquid that gasify at body 
temperature. Gas can be introduced into the floating 
chamber by the volatilization of an organic solvent (e.g., 
ether or cyclopentane) or by the carbon dioxide produced as 
a result of an effervescent reaction between organic acids 
and carbonate–bicarbonate salts. The matrices are fabricated 
so that upon arrival in the stomach, carbon dioxide is 
liberated by the acidity of the gastric contents and is 
entrapped in the gellified hydrocolloid. This produces an 
upward motion of the dosage form and maintains its 
buoyancy. Recently a multiple-unit type of floating pill, which 
generates carbon dioxide gas, has been developed. 
2. Non-effervescent systems 
Non-effervescent floating drug delivery systems are 
normally prepared from gel-forming or highly swellable 
polysaccharides or matrix forming polymers like 
polyacrylate, polycarbonate, polystyrene and 
polymethacrylate. In one approach, intimate mixing of drug 
with a gel forming hydrocolloid which results in contact with 
gastric fluid after oral administration and maintain a relative 
integrity of shape and a bulk density less than unity within 
the gastric environment. The air trapped by the swollen 
polymer confers buoyancy to these dosage forms. Excipients 
used most commonly in these systems include hydroxyl 
propyl methylcellulose(HPMC) polyacrylates, polyvinyl 
acetate, carbopol, sodium alginate, calcium chloride, 
polyethylene oxide and polycarbonates 
Factors affecting the floating drug delivery system 
a. Density: gastric retention time (GRT) is a function of 
dosage form buoyancy that is dependent on the density. 
b. Size and Shape: Dosage form unit with a diameter of 
more than 7.5 mm are reported to have an increased 
GRT competed to with those with a diameter of 9.9 mm. 
The dosage form with a shape tetrahedron and ring 
shape devises with a flexural modulus of 48 and 22.5 
kiloponds per square inch (KSI) are reported to have 
better GIT for 90 to 100% retention at 24 hours 
compared with other shapes15. 
c. Fed or Unfed State: Under fasting conditions, the 
gastro intestinal motility is characterized by periods of 
strong motor activity or the migrating myoelectric 
complexes (MMC) that occurs every 1.5 to 2 hours. The 
MMC sweeps undigested material from the stomach and 
if the timing of administration of the formulation 
coincides with that of the MMC, the GRT of the unit can 
be expected to be very short. However, in the fed state, 
MMC is delayed and GRT is considerably longer16 . 
d. Nature of the meal: Feeding of indigestible polymers of 
fatty acid salts can change the motility pattern of the 
stomach to a fed state, thus decreasing the gastric 
emptying rate and prolonging the drug release17. 
e. Caloric Content: GRT can be increased between 4 to 10 
hours with a meal that is high in proteins and fats. 
f. Frequency of feed: The GRT can increase by over 400 
minutes when successive meals are given compared 
with a single meal due to the low frequency of MMC18 . 
g. Gender: Mean ambulatory GRT in meals (3.4±0.4 hours) 
is less compared with their age and race-matched 
female counterparts (4.6±1.2 hours), regardless of the 
weight, height and body surface. 
h. Age: Elderly people, especially those over 70 years have 
a significantly longer GRT[19-20] . 
i. Posture: GRT can vary between supine and upright 
ambulatory states of the patients[21]. 
j. Concomitant drug administration: Anticholinergic 
drugs like atropine and propentheline opiates like 
codeine and prokinetic agents like metoclopramide and 
cisapride. 
NEED OF FLOATING DRUG DELIVERY SYSTEM 
Oral dosage forms pose low bioavailability problems due to 
their rapid gastric transition from stomach, especially in case 
of drugs which are less soluble at alkaline pH of intestine. 
Similarly, drugs which produce their local action in stomach 
get rapidly emptied and do not get enough residence time in 
stomach. So, frequency of dose administration in such cases 
is increased. To avoid this problem floating drug delivery 
system has been developed. Oral in situ gel forming system 
also known as stomach specific or raft forming systems have 
provided a suitable way of providing the controlled drug 
delivery within stomach with enhanced gastro-retention. 
The tablet/capsule floating dosage forms are stable as 
compare to liquids but the problem with them is that they 
are needed to swallow as whole unit. In case of dosage 
adjustment these cannot be broken in halves as these are 
also designed for controlled release and floating ability also 
depends on dimensions of tablets. Elderly patients, children 
some adult persons and patient with certain conditions 
suffer from dysphasia, so it becomes difficult for them to 
swallow tablet/capsule dosage forms. Also in case of dosage 
adjustments these floating solid dosage forms are needed to 
be available in different strengths. Where an environment 
specific gel forming solution, on conversion to gel, floats on 
the surface of the gastric fluids (due to less density than 
gastric contents). In this technique, a solution of low 
viscosity is used which on coming in contact with the gastric 
fluids, undergo change in polymeric conformation and a 
viscous gel of density lower than the gastric fluids is 
produced. This low density gel formation called as raft not 
only provide the much desired gastro retention to prolong 
the contact time, but also produce the continuous and slow 
drug release[22-23]. 
IN SITU GELLING SYSTEM 
This novel drug delivery system promotes importantly ease 
and convenience of administration, deliverance of accurate 
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dose as well as to prolong residence time of drug in contact 
with mucosa that problems generally encountered in 
semisolid dosage forms. 
In situ gel formation occurs due to one or combination of 
different stimuli like pH change, temperature modulation 
and solvent exchange. Smart polymeric systems represent 
promising means of delivering the drugs; these polymers 
undergo sol-gel transition, once administered. From the 
early 1970's natural and synthetic polymers began to be 
investigated for controlled release formulations. The 
advantages of using biodegradable polymers in clinical 
applications are apparent. Various natural and synthetic 
polymers are used for formulation development of in situ 
forming drug delivery systems. 
Mechanism of floating oral in situ gel24 
In order to increase the retention time of dosage form in the 
stomach various attempts have been made and these include 
floating dosage forms (gas-generating systems and swelling 
or expanding systems), mucoadhesive systems, high-density 
systems, modified shape systems, gastric-emptying delaying 
devices and co-administration of gastric-emptying delaying 
drugs. Among these, the floating dosage forms have been 
most commonly used. Floating drug delivery systems (FDDS) 
have a bulk density less than gastric fluids so they remain 
floating in the stomach without affecting the gastric 
emptying rate for a prolonged period of time. While the 
system is floating on the gastric contents (given in the Figure 
1 (a)), the drug is released slowly at the desired rate from 
the system. After release of drug from the system, the 
residual system is emptied from the stomach which results 
in an increased GRT and a better control of the fluctuations 
in plasma drug concentration. However, besides a minimal 
gastric content needed to allow the proper achievement of 
the buoyancy retention principle, a minimal level of floating 
force (F) is also required to keep the dosage form reliably 
floating on the surface of the meal. To measure the floating 
force kinetics, a novel apparatus for determination of 
resultant weight has been reported in the literature. The 
apparatus operates by measuring continuously the force 
equivalent to F (as a function of time) that is required to 
maintain the submerged object. The object floats better if F is 
on the higher positive side (Figure 1(b)). This apparatus 
helps in optimizing FDDS with respect to stability and 
durability of floating forces produced in order to prevent the 
drawbacks of unforeseeable intragastric buoyancy Capability 
variations.  
F = F buoyancy - F gravity  
= (Df - Ds) gv 
Where, F= total vertical force, Df = fluid density,  
Ds = object density, v = volume and  
g = acceleration due to gravity. 
 
 
Figure 1: Mechanism of floating systems25  
 
GF= Gastric fluid. 
Approaches of In- Situ Gel Drug Delivery 
Different approaches and mechanisms utilized or involved in 
producing the in situ gel formation are as follows: 
1. Physiological stimuli 
A. Temperature 
B. pH 
2. Physical changes in biomaterials 
A. Solvent exchange 
B. Swelling 
3. Chemical reactions 
A.  Enzymatic 
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B. Chemical 
C. Photo-initiated polymerization. 
In situ formation based on physiological stimuli 
 Thermally triggered system26-28 
Temperature-sensitive hydrogels are probably the most 
commonly studied class of environment-sensitive polymer 
systems in drug delivery research. The use of a biomaterial 
whose transitions from sol-gel is triggered by increase in 
temperature is an attractive way to approach in-situ 
formation. 
The ideal critical temperature range for such system is 
ambient and physiologic temperature, such that clinical 
manipulation is facilitated and no external source of heat 
other than that of body is required for trigger gelation. A 
useful system should be tolerable to account for small 
differences in local temperature, such as might be 
encountered in appendages at the surface of skin or in the 
oral cavity. 
Three main strategies exist in engineering of 
thermoresponsive sol-gel polymeric system. For 
convenience, temperature-sensitive hydrogels are classified 
into negatively thermosensitive, positively thermosensitive, 
and thermally reversible gels (1, 3). Negative temperature-
sensitive hydrogels have a lower critical solution 
temperature (LCST) and contract upon heating above the 
LCST. Polymers with low critical temperature (LCST) 
transition between ambient and physiologic temperature is 
used for this purpose. One of the most extensively 
investigated polymers that exhibit useful LCST transition is 
poly(N-isopropyl acrylamide) (PNIPAAm). PNIPAAm is a 
water soluble polymer at its low LCST, but hydrophobic 
above LCST, which result on precipitation of PNIPAAm from 
the solution at the LCST. Pluronics are poly (ethylene oxide)-
poly (propylene oxide)-poly (ethylene oxide) (PEO-PPOPEO) 
triblock co- polymer that are fluid at low temperature, but 
forms thermo responsible gel when heated as a 
consequences of a disorder-order transition in micelle 
packing which makes these polymers suitable for in situ 
gelation. A positive temperature sensitive hydrogel has an 
upper critical solution temperature (UCST), such hydrogel 
contracts upon cooling below the UCST. Polymer networks of 
poly(acrylic acid) (PAA) and polyacrylamide (PAAm) or 
poly(acrylamide-co-butyl methacrylate) have positive 
temperature dependence of swelling. The most commonly 
used thermoreversible gels are these prepared from 
poly(ethylene oxide)-b-poly(propylene oxide)-b- 
poly(ethylene oxide) (Pluronics, Tetronics, poloxamer). 
Polymer solution is a free flowing liquid at ambient 
temperature and gels at body temperature. Novel “protein 
polymers” called as ProLastins, which undergo an 
irreversible sol gel transition, when injected as a solution 
into the body, the material forms a firm, stable gel within 
minutes. It remains at the site of injection providing 
absorption times from less than one week to many months. 
Such a system would be easy to administer into desired body 
cavity. 
 pH triggered systems29-33 
Another formation of in situ gel based on physiologic stimuli 
is formation of gel is induced by pH changes. All the pH-
sensitive polymers contain pendant acidic or basic groups 
that either accept or release protons in response to changes 
in environmental pH. The polymers with a large number of 
ionizable groups are known as polyelectrolytes. Swelling of 
hydrogel increases as the external pH increases in the case of 
weakly acidic (anionic) groups, but decreases if polymer 
contains weakly basic (cationic) groups. The most of anionic 
pH- sensitive polymers are based on PAA (Carbopol®, 
carbomer) or its derivatives. Likewise poly vinyl acetal 
diethyl amino acetate (AEA) solutions with a low viscosity at 
pH 4 form hydrogel at neutral pH condition. Drug formulated 
in liquid solutions have several limitations including limited 
bioavailability and propensity to be easily removed. To 
minimize these factors and maximize this drug delivery by 
making a poly(acrylic acid) (PAA) solution that would be gel 
at pH 7.4, by that we found that at concentrations high 
enough to cause gelation, however, the low pH of PAA 
solution would cause damage to surface of eye before being 
neutralized by the lacrimal fluid. This problem was solved by 
partially by combining PAA with HPMC, a viscous enhancing 
polymer, which resulted in pH responsive polymer mixtures 
that was solution at pH 4 and gel at pH 7.4. Mixtures of poly 
(methacrylic acid) (PMA) and poly (ethylene glycol) (PEG) 
also has been used as a pH sensitive system to achieve 
gelation. 
In situ formation based on physical mechanism 
 Swelling34-36 
In situ formation may also occur when material absorbs 
water from surrounding environment and expand to occupy 
desired space. One such substance is myverol 18-99 
(glycerol mono-oleate), which is polar 1400 lipid that swells 
in water to form lyotropic liquid crystalline phase structures. 
It has some bioadhesive properties and can be degraded in 
vivo by enzymatic action. 
 Diffusion 37-38 
This method involves the diffusion of solvent from polymer 
solution into surrounding tissue and results in precipitation 
or solidification of polymer matrix. N- methyl-pyrrolidone 
(NMP) has been shown to be useful solvent for such system. 
In situ formation based on chemical reactions 
Chemical reactions that results in situ gelation may involve 
precipitation of inorganic solids from supersaturated ionic 
solutions, enzymatic processes, and photo-initiated 
processes. 
 Ionic cross linking39-44 
Polymers may undergo phase transition in presence of 
various ions. Some of the polysaccharides fall into the class 
of ion-sensitive ones .While k-carrageenan forms rigid, 
brittle gels in reply of small amount of K+, i- carrageenan 
forms elastic gels mainly in the presence of Ca2+. Gellan gum 
commercially available as Gelrite® is an anionic 
polysaccharide that undergoes in situ gelling in the presence 
of mono- and divalent cations, including Ca2+, Mg2+, K+ and 
Na. Gelation of the low-methoxypectins can be caused by 
divalent cations, especially Ca2+. Likewise, alginic acid 
undergoes gelation in presence of divalent/polyvalent 
cations e. g. Ca2+ due to the interaction with glucuronic acid 
block in alginate chains. In situ formation catalysed by 
natural enzymes has not been investigated widely but seems 
to have some advantages over chemical and photochemical 
approaches. For example, an enzymatic process operates 
efficiently under physiologic conditions without need for 
potentially harmful chemicals such as monomers and 
initiators. Intelligent stimuli-responsive delivery systems 
using hydrogels that can release insulin have been 
investigated. Cationic pH-sensitive polymers containing 
immobilized insulin and glucose oxidase can swell in 
response to blood glucose level releasing the entrapped 
insulin in a pulsatile fashion. Adjusting the amount of 
enzyme also provides a convenient mechanism for 
controlling the rate of gel formation, which allows the 
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mixtures to be injected before gel formation. 
 Enzymatic cross-linking45-47 
In situ formation catalysed by natural enzymes has not been 
investigated widely but seems to have some advantages over 
chemical and photochemical approaches. For example, an 
enzymatic process operates efficiently under physiologic 
conditions without need for potentially harmful chemicals 
such as monomers and initiators. Intelligent stimuli-
responsive delivery systems using hydrogels that can release 
insulin have been investigated. Cationic pH-sensitive 
polymers containing immobilized insulin and glucose 
oxidase can swell in response to blood glucose level 
releasing the entrapped insulin in a pulsatile 
fashion.Adjusting the amount of enzyme also provides a 
convenient mechanism for controlling the rate of gel 
formation, which allows the mixtures to be be injected 
before gel formation. 
 Photo Polymerisation48-51 
Photo-polymerisation is commonly used for in situ formation 
of biomaterials. A solution of monomers or reactive 
macromer and initiator can be injected into a tissues site and 
the application of electromagnetic radiation used to form gel. 
Acrylate or similar polymerizable functional groups are 
typically used as the polymerizable groups on the individual 
monomers and macromers because they rapidly undergo 
photo- polymerisation in the presence of suitable 
photoinitiator. Typically long wavelength ultraviolet and 
visible wavelengths are used. Short wavelength ultraviolet is 
not used often because it has limited penetration of tissue 
and biologically harmful. A ketone, such as 2,2- dimethoxy-2-
phenyl acetophenone, is often used as the initiator for 
ultraviolet photo- polymerization, where as 
camphorquinone and ethyl eosin initiators are often used in 
visible light systems. These systems can be designed readily 
to be degraded by chemical or by enzymatic processes or can 
be designed for long term persistence in-vivo. Photo 
polymerizable systems when introduced to the desired site 
via injection get photocured in situ gel with the help of fiber 
optic cables and then release the drug for prolonged period 
of time. The photo-reactions provide rapid polymerization 
rates at physiological temperature. Furthermore, the 
systems are easily placed in complex shaped volumes to an 
implant formation. 
 
Table 1: Commercial Formulations of In Situ Polymeric Systems51-53 
Dosage Form Drugs Brand Name Company Country 
Opthalmic Timolol maleate Timoptic-XE Merck and Co 
Regel:depot-technology Paclitaxel Oncogel Macromed’s drug delivery 
Injectable depot formulation Interleukin -2 Cytoryn Macromed’s drug delivery 
Ophthalmic Lidocaine HCl Akten  
Ophthalmic solution Azithromycin Azasite Insite Vision 
                                         
Table 2: Marketed Products of FDDS 
Dosage Form Drugs Brand Name Company;Country 
Floatingk Controlled Release 
Capsule 
Levodopa, 
Benserazide 
MODAPAR Roche Products,USA 
Floating Capsule Diazepam VALRELEASE Hoffmann-LaRoche,USA 
Effervescent Floating Liquid 
alginate Preparation 
Aluminium 
hydroxide, 
Magnesium 
carbonate 
LIQUID 
GAVISON 
Glaxo Smith Kline,INDIA 
Floating Liquid alginate 
Preparation 
Aluminium - 
Magnesium antacid 
TOPALKAN Pierre Fabre Drug,FRANCE 
Colloidal gel forming FDDS Ferrous sulphate CONVIRON Ranbaxy,INDIA 
G;2as-generating floating 
Tablets 
Ciprofloxacin CIFRAN OD Ranbaxy,INDIA 
Bilayer floating Capsule Misoprostil CYTOTEC Pharmacia,USA 
 
RECENT ADVANCES 
One of the challenges facing today's pharmaceutical industry 
centers on coming up with efficient treatment options that 
are readily acceptable to physicians and patients. Delivery 
systems must also contribute to a better therapeutic 
outcome if they are going to provide viable alternatives to 
pharmaceuticals currently delivered by other routes. In situ 
gel formulations are one of the challenging drug delivery 
systems. 
Various biodegradable polymers are used for formulation of 
in situ gels, but there are fabrication problems, difficult in 
processing, use of organic solvents for their preparation 
(especially for synthetic polymer based systems), burst effect 
and irreproducible drug release kinetics. Natural polymers 
satisfy the characteristics of an ideal polymer but batch to 
batch reproducibility is difficult therefore synthetic 
polymers are used. 
Poly(ether-ester) based biodegradable block copolymers are 
available such as poly(ethylene oxide)-poly(lactic acid) i.e. 
(PEO-PLA) copolymer, poly(ethyleneoxide)-
poly(caprolactone) i.e. (PEO-PCL), poly(ethyleneglycol)-
poly(lactide-co-glycolide)-poly(ethylene glycol) i.e. (PEG-
PLGA-PEG) copolymer may also be used for formation of in 
situ injectable hydrogels showing improved biocompatibility, 
biodegradability, reduced burst effect, better mechanical 
strength and processability 
The recent advancement of biotechnologies has led to the 
development of labile macromolecular therapeutic agents 
that require complex formulations for their efficient 
administration. N-stearoyl L-alanine(m)ethyl esters when 
mixed with a vegetable oil and a biocompatible hydrophilic 
solvent led to the formation of injectable, in situ-forming 
organogel. Following subcutaneous injection, leuprolide-
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loaded organogel degraded and gradually released 
leuprolide for 14 to 25d. 
FUTURE PROSPECTS 
Herbal drug delivery is the emerging field in the pharmacy. 
The use of floating drug delivery system for herbal 
medicament is the novel approach for the better delivery of 
drugs. For this purpose there is a great opportunity to work 
on GI transit profiles. This has given rise to new products 
with substantial benefits to the patients. Now with the 
advent of FDDS the products have been designed which 
could release drug for upto 24 hrs. Some herbals that can be 
delivered as floating drug delivery systems are: 
Black Myrobalan 
The aqueous extract of black myrobalan (familiar with 
Terminalia chebula Retz) has been shown to have uniform 
antibacterial activity against ten clinical strains of H. pylori. 
Ginger 
Ginger root (familiar with Zingiber officinale Rosc.) has been 
used traditionally for the treatment of gastrointestinal 
ailments such as motion sickness, dyspepsia and 
hyperemesis gravidarum, and is also reported to have chemo 
preventative activity in animal models. 
Turmeric 
Curcumin, a polyphenolic chemical constituent derived from 
turmeric (familiar with Curcuma longa L.), has been shown 
to prevent gastric and colon cancers in rodents .various 
mechanisms had been proposed for the chemo preventative 
effects, although the effect of curcumin on the growth of H. 
pylori has not been reported.  
Licorice 
In a recent study at the Institute of Medical Microbiology and 
Virology, Germany, researchers found that licorice extract 
produced a potent effect against strains of H. pylori that are 
resistant against clarithromycin, one of the antibiotics 
typically used in the three antibiotic treatment regimens. 
CONCLUSION 
In conclusion, the primary requirement of a successful 
controlled release product focuses on increasing patient 
compliance which the in situ gels offer. Exploitation of 
polymeric in- situ gels for controlled release of various drugs 
provides a number of advantages over conventional dosage 
forms. Sustained and prolonged release of the drug, good 
stability and biocompatibility characteristics make the in situ 
gel dosage forms very reliable. Use of biodegradable and 
water soluble polymers for the in situ gel formulations can 
make them more acceptable and excellent drug delivery 
systems. In-situ drug delivery provides a great potential for 
development of liquid orals for their sustained drug release. 
This floating in-situ gel approach is suitable for drugs having 
narrow absorption window in stomach or drugs showing 
local effect in stomach. These types of drugs which are 
currently present in market as their solid dosage forms 
(tablets or capsules) will be available as their floating in-situ 
gels. 
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